Akèy › Skleroderm Difize
Etid klinik pou Skleroderm Difize ap rekrite nan Etazini
22 etid pou Skleroderm Difize ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY8 etid
- Chicago, IL7 etid
- Ann Arbor, MI7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Baltimore, MD5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Pittsburgh, PA4 etid
- Kansas City, KS4 etid
- New Orleans, LA4 etid
- Philadelphia, PA4 etid
- Cedar Rapids, IA3 etid
- Charleston, SC3 etid
- Aurora, CO3 etid
- Phoenix, AZ3 etid
- Jacksonville, FL3 etid
- Charlotte, NC3 etid
- Plantation, FL3 etid
- Dallas, TX3 etid
Pa eta
- Arizona5 etid
- Colorado3 etid
- Florid8 etid
- Illinois8 etid
- Iowa3 etid
- Kalifòni9 etid
- Kansas5 etid
- Lwizyàn4 etid
- Maryland5 etid
- Massachusetts5 etid
- Michigan7 etid
- Minnesota4 etid
- New Jersey3 etid
- New York9 etid
- North Carolina8 etid
- Pennsylvania6 etid
- South Carolina3 etid
- Tennessee4 etid
- Texas7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT06470048Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04797286EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07287670A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Ap rekriteFaz 2
Laj 8 a 60 · Tout sèks · Mizajou Aug 14, 2026 · NCT03630211A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07090226A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745US Zamto-cel Autoimmune Diseases
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06708845A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07047690Rheumatology Patient Registry and Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Feb 13, 2026 · NCT04402086Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Fanm · Mizajou Jan 8, 2026 · NCT03276923The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT06675344Scleroderma Registry & Repository at the Hospital for Special Surgery
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 26, 2025 · NCT01656447Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 29, 2025 · NCT01793168Rheumatology Diet Study
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou Dec 6, 2024 · NCT06339957Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.